Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
96.2M
-
Shares change
-
-1.14M
-
Total reported value, excl. options
-
$1.35B
-
Value change
-
-$24.9M
-
Put/Call ratio
-
0.96
-
Number of buys
-
89
-
Number of sells
-
-80
-
Price
-
$14.07
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q4 2021
239 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q4 2021.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96.2M shares
of 117M outstanding shares and own 82.03% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (16.2M shares), Bain Capital Life Sciences Investors, LLC (8.42M shares), BlackRock Inc. (7.87M shares), STATE STREET CORP (6.25M shares), VANGUARD GROUP INC (5.9M shares), Chicago Capital, LLC (5.73M shares), PFM Health Sciences, LP (3.81M shares), Fisher Asset Management, LLC (3.61M shares), BLAIR WILLIAM & CO/IL (2.24M shares), and D. E. Shaw & Co., Inc. (2.08M shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.